Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (761-770 of 1,095) with videos related to

Pageof 110
Sort By:
Tumori|May 4, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinomaAlessandro Rametta, Sebastiano Buti, Marco Stellato, et al.
Therapeutic Advances in Urology|July 26, 2023
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective studyChiara Tommasi, Giulia Scartabellati, Diana Giannarelli, et al.
Virus Evolution|May 6, 2026
Peaked-to-flat transition in quasispecies structure evolutionJosep Gregori, Sergi Colomer-Castell, Carolina Campos, et al.
Anti-Cancer Drugs|December 20, 2022
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinomaSebastiano Buti, Chiara Tommasi, Giulia Scartabellati, et al.
ACS Nano|November 6, 2023
An Integrated Multilevel Approach Unveils Complex Seed-Nanoparticle Interactions and Their Implications for Seed PrimingElisa Cappetta, Carmine Del Regno, Marisa Conte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2022
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatinR Iacovelli, C Ciccarese, M Brunelli, et al.
Cancer Treatment and Research Communications|November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studySebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
The New England Journal of Medicine|August 16, 2013
Faldaprevir and deleobuvir for HCV genotype 1 infectionStefan Zeuzem, Vincent Soriano, Tarik Asselah, et al.
Clinical Genitourinary Cancer|January 22, 2017
First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA StudySebastiano Buti, Melissa Bersanelli, Francesca Maines, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2025
Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary CareElena Vargas-Accarino, Ariadna Rando-Segura, María Asunción Úbeda, et al.
Pageof 110

Showing results (761-770 of 1,095) with videos related to

Sort By:
Pageof 110
Tumori|May 4, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinomaAlessandro Rametta, Sebastiano Buti, Marco Stellato, et al.
Therapeutic Advances in Urology|July 26, 2023
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective studyChiara Tommasi, Giulia Scartabellati, Diana Giannarelli, et al.
Virus Evolution|May 6, 2026
Peaked-to-flat transition in quasispecies structure evolutionJosep Gregori, Sergi Colomer-Castell, Carolina Campos, et al.
Anti-Cancer Drugs|December 20, 2022
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinomaSebastiano Buti, Chiara Tommasi, Giulia Scartabellati, et al.
ACS Nano|November 6, 2023
An Integrated Multilevel Approach Unveils Complex Seed-Nanoparticle Interactions and Their Implications for Seed PrimingElisa Cappetta, Carmine Del Regno, Marisa Conte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2022
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatinR Iacovelli, C Ciccarese, M Brunelli, et al.
Cancer Treatment and Research Communications|November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studySebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
The New England Journal of Medicine|August 16, 2013
Faldaprevir and deleobuvir for HCV genotype 1 infectionStefan Zeuzem, Vincent Soriano, Tarik Asselah, et al.
Clinical Genitourinary Cancer|January 22, 2017
First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA StudySebastiano Buti, Melissa Bersanelli, Francesca Maines, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2025
Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary CareElena Vargas-Accarino, Ariadna Rando-Segura, María Asunción Úbeda, et al.
Pageof 110